Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06987253

Assessment of the Efficacy and Safety of OROXID® Oral Solution in Patients With Oral Cavity Surgery

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
ENIKAM d.o.o. · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Oral tissue healing is significantly affected by the high bacterial load and constant mechanical stress within the oral cavity. To control bacterial colonization and support healing, both topical and systemic treatments-such as antibiotics and anti-inflammatory agents-are commonly recommended. In addition to pharmacological therapies, mouthwashes containing peroxide, hyaluronic acid, chitosan, or chlorhexidine are often used to maintain low levels of pathogenic bacteria. However, current recommendations for mouthwash use are primarily based on their antibacterial properties in a healthy oral environment. Evidence supporting their role in promoting wound healing, particularly after oral surgery, remains limited. OROXID® mouthwash is a medical device formulated with active oxygen (peroxide compounds). It supports the prevention and relief of inflammation in gingival and paranasal tissues through mechanical action: the release of oxygen bubbles helps cleanse tissues by removing debris. OROXID® acts locally on the mucosal microenvironment by moistening, oxygenating, and clearing away particles and dead cells. Additionally, its slightly acidic pH (between 3 and 5) helps inhibit microbial growth. The investigators hypothesize that OROXID® may reduce post-operative side effects and complications following wisdom tooth extraction and contribute to faster wound healing.

Conditions

Interventions

TypeNameDescription
DEVICEOROXID® forte oral solutionPatients will use OROXID® forte oral solution two to three times daily for 14 days as an adjunct to standard care.
OTHERStandard of Care (SOC)Patients will receive standard of care meaning proper tooth brushing without the use of any mouthwash or other products aimed at reducing bacteria in the oral cavity.

Timeline

Start date
2025-11-06
Primary completion
2026-05-31
Completion
2026-05-31
First posted
2025-05-23
Last updated
2025-12-01

Locations

1 site across 1 country: Slovenia

Source: ClinicalTrials.gov record NCT06987253. Inclusion in this directory is not an endorsement.